Showing results (1311-1320 of 1,717) with videos related to
Sort By:
Pageof 172
Blood|July 7, 2022
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNHartmut Döhner, Andrew H Wei, Frederick R Appelbaum, et al.Science Advances|March 5, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small moleculesKaiming Li, Yu Q Yap, Donia M Moujalled, et al.Annals of Surgery|April 22, 2024
Association of Lateral Pelvic Lymph Nodes with Disease Recurrence and Organ Preservation in Patients with Distal Rectal Adenocarcinoma Treated with Total Neoadjuvant TherapyNathalie R A Beets, Floris S Verheij, Hannah Williams, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 19, 2018
[Characteristics and prognosis in adult acute myeloid leukemia patients with MLL gene rearrangements]X Y Gong, Y Wang, B C Liu, et al.Blood Cancer Journal|April 21, 2022
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemiaKeith W Pratz, Panayiotis Panayiotidis, Christian Recher, et al.Leukemia|March 24, 2020
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 studyPau Montesinos, Gail J Roboz, Claude-Eric Bulabois, et al.Internal Medicine Journal|January 9, 2026
Flow cytometric assessment of measurable residual disease in acute myeloid leukaemia: a summary of current Australasian practice and future directionsKah Lok Chan, Edward A Abadir, Esther Aklilu, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 25, 2021
[Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China]Y Wen, L Z Yu, L B Du, et al.Blood|August 12, 2024
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendationsHartmut Döhner, Courtney D DiNardo, Frederick R Appelbaum, et al.The American Journal of Surgical Pathology|March 21, 2024
The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 CasesOluwole Fadare, Elmira Vaziri Fard, Rohit Bhargava, et al.Pageof 172